Compartir
Título
RespiraConNosotros: a viable home-based telerehabilitation system for respiratory patients
Autor(es)
Palabras clave
COVID-19
SARS-CoV-2
home therapy
pulmonary
respiratory exercises
telerehabilitation
Fecha de publicación
2021
Editor
https://www.mdpi.com/1424-8220/21/10/3318
Citación
Bermejo-Gil, B.M.; Pérez-Robledo, F.; Llamas-Ramos, R.; Silva, L.A.; Sales-Mendes, A.; Leithardt, V.R.Q.; Llamas-Ramos, I. RespiraConNosotros: A Viable Home-Based Telerehabilitation System for Respiratory Patients. Sensors 2021, 21, 3318. https://doi.org/10.3390/s21103318
Resumen
Currently, there are more than 1.55 million cases of SARS-CoV-2 infection in Spain. Of these, it is estimated that around 45% will present respiratory complications, which represents approximately 620,000 patients who will need respiratory rehabilitation. The health system has no resources for this huge quantity of patients after the hospital discharge to finish the complete recovery and avoid the chronicity of the symptoms. We propose an application named RespiraConNosotros. The application has been created and designed to guide users in performing respiratory rehabilitation exercises, especially for COVID-19 patients, and it also facilitates patient–physiotherapist contact via chat or video calling to help patients. It is accessible for all users and on all devices. All exercises would be guided and supervised by a specialized physiotherapist who suggests, adapts, and guides the exercise according to the function level of each patient. Data obtained was satisfactory; all patients pointed out the easy access, the intuitive format, and the advantage of communicating with an expert. Concerning functional assessment, all participants improved their score on the Borg scale after performing the intervention with the application.This platform would help respiratory patients to make rehabilitation treatments to recover their pulmonary function and to decrease or eliminate the possible complications they have. It never substitutes any prescribed treatment. In conclusion, RespiraConNosotros is a simple, viable, and safe alternative for the improvement and maintenance of respiratory capacity and patient’s functionality affected by COVID-19. It could be used as a complement to face-to-face treatment when the situation allows it.
URI
DOI
10.3390/s21103318
Versión del editor
Aparece en las colecciones












